Erik Nilsson

Title: The Innovations of Erik Nilsson

Introduction

Erik Nilsson is a notable inventor based in Linköping, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of expression vectors. His work has implications for the production of recombinant proteins, which are essential in various medical and industrial applications.

Latest Patents

Erik Nilsson holds a patent for "Expression vectors with modified ColE1 origin of replication for control of plasmid copy number." This invention involves an expression vector that utilizes a ColE1 replication system. The innovation modifies the homology of the RNAI and RNAII of the ColE1 origin of replication through mutations in the coding region of the RNAI gene and corresponding mutations in the RNAII gene. The result is a stable maintenance of plasmid copy number in methods using this vector for producing recombinant proteins. Additionally, high plasmid copy numbers can be achieved in methods for plasmid production.

Career Highlights

Erik Nilsson is currently employed at Boehringer Ingelheim International GmbH, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficiency of plasmid production, which is crucial for various biotechnological applications.

Collaborations

Erik has collaborated with notable colleagues such as Karl Bayer and Reingard Grabherr. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Erik Nilsson's contributions to biotechnology through his patent and work at Boehringer Ingelheim International GmbH highlight his role as a significant inventor in the field. His innovations continue to impact the production of recombinant proteins, showcasing the importance of his research in advancing biotechnological applications.